ANIP SG&A Expenses

Ani Pharmaceuticals Inc · SG&A Expenses

ANIP logo

ANIP SG&A Expenses

Latest reported$324.76M
ANIP SG&A Expenses ($1.11M → $324.76M)
High-resolution chart · PNG

ANIP sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
317,745,000
249,636,000
161,697,000
124,044,000
84,294,000
64,986,000
55,843,000
44,063,000
31,580,000
27,829,000
21,156,000
17,935,000
16,388,000
8,229,523
6,981,490
5,940,360
5,673,561
5,961,354
4,331,361
7,025,418
3,050,555
3,080,135
2,327,090
1,765,624
2,298,659
1,678,581
853,389
1,112,647
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.